I can't get the formatting correct, Koo; but, here's the information from the website...

Medical condition:CORONAVIRUS DISEASE (COVID-19)Study population:ADULT FEMALE, ADULT MALEDrug name:RVX000222 (APABETALONE)Protocol title:AN OPEN-LABEL STUDY TO ASSESS THE SAFETY AND EFFECT ON CLINICAL COURSE AND KEY BIOMARKERS OF ORAL APABETALONE IN HOSPITALIZED SUBJECTS WITH COVID-19 INFECTION IN ADDITION TO STANDARD OF CARE (SOC)Protocol number:RVX222-CS-023Sponsor name:RESVERLOGIX CORPDate of no objection letter:2021-04-06Control number:250480Trial status:PENDINGDate study started:Date study completed: